Beneficial effect of genistein on lowering blood pressure and kidney toxicity in fructose-fed hypertensive rats

British Journal of Nutrition

Volumn 109, Issue 10, 2013, Pages 1806-1812

  Palanisamy, Nallasamy ^a   Venkataraman, Anuradha C ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Blood pressure; Endothelial nitric oxide synthase; Fructose; Genistein; Nitric oxide

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRUCTOSE; GENISTEIN; KALLIKREIN; LIPID; NITRIC OXIDE; NITRILE; PROTEIN KINASE C BETA; STARCH;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; ENZYME ACTIVATION; HEART RATE; HISTOPATHOLOGY; HYPERTENSION; KIDNEY CELL; LIPID COMPOSITION; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; ULTRASTRUCTURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; DIET; DIETARY SUCROSE; FRUCTOSE; GENISTEIN; HEART RATE; HYPERTENSION; KALLIKREINS; KIDNEY; LIPID METABOLISM; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; PEPTIDYL-DIPEPTIDASE A; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN KINASE C; RATS; RATS, WISTAR; SOYBEANS;

RATTUS; RATTUS NORVEGICUS;

EID: 84878019574     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512003819     Document Type: Article

References (36)

1. Reaven GM (1994) Syndrome X: six years later. J Int Med 736, 13-22.
2. Sanchez-Lozada LG, Tapia E, Jimenez A, et al. (2007) Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292, 423-429.
3. Haller H, Baur E, Quass P, et al. (1995) High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47, 1057-1067.
4. Rajasekar P, Palanisamy N & Anuradha CV (2007) Increase in nitric oxide and reductions in blood pressure, protein kinase C beta II and oxidative stress by L-carnitine: a study in the fructose-fed hypertensive rat. Clin Exp Hypertens 29, 517-530.
5. Nishimoto Y, Tomida T, Matsui H, et al. (2002) Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats. Hypertension 40, 190-194.
6. Park SA, Choi MS, Cho SY, et al. (2006) Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci 79, 1207-1213.
7. Kojima T, Uesugi T, Toda T, et al. (2002) Hypolipidemic action of the soybean isoflavones genistein and genistin in glomerulonephritic rats. Lipids 37, 261-265.
8. Palanisamy N, Viswanathan P & Anuradha CV (2008) Effect of genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet. Ren Fail 30, 645-654.
9. Rock E, Astier C, Lab C, et al. (1995) Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes Res 8, 237-242.
10. Holmquist B, Bünning P & Riordan JF (1979) A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 95, 540-548.
11. Trautschold I, Werle E & Schweitzer G (1974) Methods in Enzymatic Analysis, vol. 2, New York, NY: Academic Press, Inc.
12. Raghuramulu N, Madhavan Nair K & Kalyanasundaram K (2003) A Manual of Laboratory Techniques, 2nd ed. Hyderabad: National Institute of Nutrition Press.
13. Lowry OH, Rosebrough NJ, Farr AL, et al. (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
14. Vasdev S, Gill V, Parai S, et al. (2002) Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats. Mol Cell Biochem 241, 107-114.
15. Bhanot S, Salh BS, Verma S, et al. (1999) In vivo regulation of protein-serine kinases by insulin in skeletal muscle of fructose-hypertensive rats. Am J Physiol 277, 299-307.
16. Vasdev S, Longerich L & Gill V (2004) Prevention of fructose-induced hypertension by dietary vitamins. Clin Biochem 37, 1-9.
17. Xu YY, Yang C & Li SN (2006) Effects of genistein on angiotensin-converting enzyme in rats. Life Sci 79, 828-837.
18. Montenegro MF, Pessa LR & Tanus-Santos JE (2009) Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. Eur J Pharmacol 607, 173-177.
19. Kamata K & Yamashita K (1999) Insulin resistance and impaired endothelium-dependent relaxation in fructose-hypertensive rats. Am J Hypertens 9, 370-376.
20. Oshida Y, Tachi Y, Morishita Y, et al. (2000) Nitric oxide decreases insulin resistance induced by high-fructose feeding. Horm Metab Res 32, 339-342.
21. Mahn K, Borras C, Knock GA, et al. (2005) Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19, 1755-1757.
22. Räthel TR, Leikert JF, Vollmar AM, et al. (2005) The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro. Br J Pharmacol 144, 394-399.
23. Si H & Liu D (2008) Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J Nutr 138, 297-304.
24. Kuboki K, Jiang ZY, Takahara N, et al. (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101, 676-681.
25. Chen WF & Wong MS (2004) Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endocrinol Metab 89, 2351-2359.
26. Choi HN, Park YH, Kim JH, et al. (2011) Renoprotective and antioxidant effects of Saururus chinensis Baill in rats fed a high-fructose diet. Nutr Res Pract 5, 365-369.
27. Vaziri ND & Norris K (2011) Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purif 31, 189-196.
28. Morena M, Patrier L, Jaussent I, et al. (2011) Reduced glo-merular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients. Free Radic Res 45, 735-745.
29. Mezei O, Banz WJ, Steger RW, et al. (2003) Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133, 1238-1243.
30. Koya D & King GL (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-866.
31. Pfaff IL & Vallon V (2002) Protein kinase C beta isoenzymes in diabetic kidneys and their relation to nephroprotective actions of the ACE inhibitor lisinopril. Kidney Blood Press Res 25, 329-340.
32. Xu JW, Ikeda K & Yamori Y (2004) Genistein inhibits expressions of NADPH oxidase p22 phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27, 675-683.
33. Nevala R, Lassila M, Finckenberg P, et al. (2002) Genistein treatment reduces arterial contractions by inhibiting tyrosine kinases in ovariectomized hypertensive rats. Eur J Pharmacol 452, 87-96.
34. Vera R, Galisteo M, Villar IC, et al. (2005) Soy isoflavones improve endothelial function in spontaneously hypertensive rats in an estrogen-independent manner: role of nitric-oxide synthase, superoxide, and cyclooxygenase metabolites. J Pharmacol Exp Ther 314, 1300-1309.
35. Mishra SK, Abbot SE, Choudhury Z, et al. (2000) Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovasc Res 46, 539-546.
36. Bermejo A, Zarzuelo A & Duarte J (2003) In vivo vascular effects of genistein on a rat model of septic shock induced by lipopolysaccharide. J Cardiovasc Pharmacol 42, 329-338.